Here are relevant reports on : us-cheese-market
-
Strategic Analysis & Forecast of US Biopharmaceutical Industry – (2009-2016): Impact of Healthcare Reform, Technological Innovation & Market
The U.S. biopharmaceuticals market is expected to increase to $144 billion by 2016. The growth is expected as a result of the launch of new products, approval of new indications for existing therapies and drugs, and increase in population aged 65 years and above. From 2009 to 2016 the U.S. market revenues are forecasted to grow at a compound annual growth rate (CAGR) of 11.2%.
- Published: February 2011
- Price: $ 4950
- TOC Available:
-
Obama’s Healthcare Reform Bill and its Impact on the U.S. Healthcare Markets – (Pharmaceuticals, Medical devices and Health insurance)
The US healthcare system ranks 37 among health care systems of about 200 worldwide countries ranked by World Health Organization. US health care system is considered as one of the most expensive healthcare system in the world, spending about 16% of its GDP on healthcare. However the rising healthcare costs and increasing health premiums rates along with high number of uninsured people (about 47 million i.e. 16% of the total population) are among the significant factors contributing to the need of health reform in the US. Health reform in the US is looked upon as an initiative towards provision of qualitative and affordable health coverage for all Americans, decrease in rising burden of healthcare costs and improvement in quality & efficiency of health care. Obama has signed health reform in to law, recently in March 2010, to improve the inefficiencies of the existing health care structure. The health reform bill outlays several provisions such as universal health coverage, cost containment, increase in insurance market competition, excise tax on medical device manufacturers and lower drug costs for Medicaid and Medicare are few to mention. Thus the provisions in the health reform directly and indirectly impact the US healthcare/pharmaceutical industry and its stakeholders.
- Published: August 2010
- Price: $ 4950
- TOC Available:
-
U.S. Electronic Medical Records (EMR - Physician Office & Hospital) Market - Emerging Trends (Smart Cards, Speech Enabled EMR), Market Share, Winning Strategies, Adoption & Forecasts till 2015
EMR is a part of healthcare information technology that is used to make paperless computerized patient data in order to increase efficiency of hospital systems and reduce chances of errors in medical records. A substantial growth rate (More than 16%) of the U.S. healthcare IT spending and the government initiatives towards development of a nationwide healthcare information network is expected to push EMR implementation across the healthcare sector in the U.S. The rising demand for the healthcare cost containment and need to improve the quality of healthcare service are driving the growth of the EMR market in the U.S. The U.S. EMR market is expected to grow from $2,177 million in 2009 to $6,054 million in 2015 at an estimated CAGR of 18.1% during the forecast period 2010-2015.
- Published: June 2011
- Price: $ 4950
- TOC Available:
-
US General Anesthesia Drugs Market by Route of Administration (Intravenous and Inhalational), End User (Hospitals, Ambulatory Surgery Centers) - Global Forecast to 2025
The global US general anesthesia drugs market in terms of revenue was estimated to be worth $2.0 billion in 2020 and is poised to reach $2.4 billion by 2025, growing at a CAGR of 3.4% from 2020 to 2025. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.
- Published: February 2021
- Price: $ 4950
- TOC Available:
-
U.S. Cervical Cancer Screening Market by Test Type (PAP, HPV), Kit Type (PAP, HPV), End User (Hospitals, Laboratories, Physicians’ Offices & Clinics) - Global Forecast to 2020
The global cervical cancer screening market was approximately $15 billion in 2014 and is estimated to grow at a CAGR of 7.0% to reach nearly $22 billion by 2020. PAP test is the largest segment of the global cervical cancer screening market. However, HPV/co-test will be the fastest-growing product segment during the forecast period.
- Published: December 2026
- Price: $ 4950
- TOC Available:
-
US Generative AI Market by Software (Foundation Models, Model Enablement & Orchestration Tools, Gen AI SaaS), Modality (Text, Code, Video, Image, Multimodal), Application (Content Management, BI & Visualization, Search & Discovery) - Forecast to 2032
The US generative AI market size is projected to grow from USD 25.78 billion in 2025 to USD 279.44 billion by 2032, at a CAGR of 40.6% during the forecast period.The Key Players include IBM (US), NVIDIA (US), OpenAI (US), Anthropic (US), Meta (US), HPE (US), AMD (US), Oracle (US), Innodata (US), iMerit (US), Salesforce (US), Telus Digital (US), Microsoft (US), Google (US), AWS (US), Adobe (US), Certific (US), Fractal Analytics (US), Tiger Analytics (US), Quantiphi (US), Databricks (US), Dialpad (US), Simplified (US), Hugging Face (US), Persado (US), Copy.AI (US), Synthesis AI (US), Hypotenuse AI (US), Together AI (US), Adept (US), Writesonic (US), Inflection AI (US), Jasper (US), Runway (US), Inworld AI (US), Typeface (US), H2O.ai (US), Speechify (US), Midjourney (US), FireFiles (US), Forethought (US), Character.AI (US), Cursor (US), DeepSeek (US), XAI (US), Abridge (US), Perplexity AI (US), SambaNova (US), Scale AI (US), Labelbox (US), and HQE Systems (US).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Atrial Fibrillation Surgery Market by Procedure (Catheter Ablation, Surgical Ablation/Maze), Product (Catheter Ablation, Surgical Ablation), and Geography (Canada, China, France, Germany, India, Japan, U.S., U.K.) - Global Forecast to 2020
The global AF surgery product market was worth $791.5 Million in 2014 and is estimated to reach $1.73 Billion by 2020. This market is segmented on the basis of surgical procedures into catheter ablation and surgical ablation. Catheter and surgical ablation procedures are well accepted for the treatment of atrial fibrillation. Catheter ablation holds a larger market share and is poised to grow at a CAGR of 14.5% during the forecast period.
- Published: December 2015
- Price: $ 4950
- TOC Available:
-
US Cryogenic Equipment Market by Equipment (Tanks, Valves, Vaporizers, Pumps), Cryogen (Nitrogen, Argon, Oxygen, LNG, Hydrogen), End-use Industry (Energy & Power, Chemicals, Metallurgy, Transportation), and Application - Forecast to 2030
The US cryogenic equipment market is projected to be valued at USD 2.84 billion in 2025 and USD 4.65 billion by 2030, registering a CAGR of 10.4% during the forecast period. The Key Players Linde plc (Ireland), Chart Industries (US), Cryofab Inc. (US), Air Products and Chemicals, Inc (US), and Taylor-Wharton (US).
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
US Electrosurgery Market by Product [Instruments (Bipolar, Monopolar), Accessories, Generators, Smoke Evacuation Systems], Surgery (Orthopedic, Cosmetic, Oncology, Urology, Neurology), End User (Hospitals, Ambulatory Surgical Centers) - Forecast to 2031
The US electrosurgery market, valued at USD 2.80 billion in 2025, stood at USD 2.94 billion in 2026 and is projected to advance at a resilient CAGR of 7.0% from 2026 to 2031, culminating in a forecasted valuation of USD 4.13 billion by the end of the period. The US electrosurgery market is experiencing strong growth, mainly driven by the increasing preference for minimally invasive surgery across various specialties, which requires the use of precise electrosurgical instruments.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Synthetic Stem Cells Market by Application (Cardiovascular Disease, Neurological Disorders, Other Applications (Cancer, Diabetes, Gastrointestinal, Musculoskeletal Disorders)), Region (North America (US, Canada), Europe, APAC, RoW) - Global Forecast to 2028
The market size for synthetic stem cells is expected to grow from USD 14 million in 2023 to USD 37 million by 2028, at a CAGR of 22.5% during the forecast period. The ethical concerns on the use of embryonic stem cells and the risk of tumor formation and immune response to natural stem cells are the key factors driving the growth of this market. The key developers of synthetic stem cell technology are North Carolina State University (NCSU) (US) and Zhengzhou University (China).
- Published: December 2018
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50